Cite
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
MLA
Mendoza, Nicolás, et al. “Eligibility Criteria for Menopausal Hormone Therapy (MHT): A Position Statement from a Consortium of Scientific Societies for the Use of MHT in Women with Medical Conditions. MHT Eligibility Criteria Group.” Maturitas, vol. 166, Dec. 2022, pp. 65–85. EBSCOhost, https://doi.org/10.1016/j.maturitas.2022.08.008.
APA
Mendoza, N., Ramírez, I., de la Viuda, E., Coronado, P., Baquedano, L., Llaneza, P., Nieto, V., Otero, B., Sánchez-Méndez, S., de Frutos, V. Á., Andraca, L., Barriga, P., Benítez, Z., Bombas, T., Cancelo, M. J., Cano, A., Branco, C. C., Correa, M., Doval, J. L., … Calaf, J. (2022). Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. Maturitas, 166, 65–85. https://doi.org/10.1016/j.maturitas.2022.08.008
Chicago
Mendoza, Nicolás, Isabel Ramírez, Esther de la Viuda, Pluvio Coronado, Laura Baquedano, Plácido Llaneza, Verónica Nieto, et al. 2022. “Eligibility Criteria for Menopausal Hormone Therapy (MHT): A Position Statement from a Consortium of Scientific Societies for the Use of MHT in Women with Medical Conditions. MHT Eligibility Criteria Group.” Maturitas 166 (December): 65–85. doi:10.1016/j.maturitas.2022.08.008.